Core Insights - Privia Health reported revenue of $521.15 million for the quarter ended June 2025, reflecting a year-over-year increase of 23.4% and a positive surprise of 11.24% over the Zacks Consensus Estimate of $468.49 million [1] - The company's EPS was $0.02, down from $0.03 in the same quarter last year, resulting in a negative surprise of 60% compared to the consensus estimate of $0.05 [1] Financial Performance Metrics - Practice Collections reached $862.9 million, exceeding the five-analyst average estimate of $804.11 million [4] - Care Margin was reported at $115.2 million, also above the five-analyst average estimate of $109.25 million [4] - Platform Contribution amounted to $57.5 million, surpassing the average estimate of $52.25 million from five analysts [4] - The number of Implemented Providers at the end of the period was 5,125, exceeding the average estimate of 4,967 from two analysts [4] - Value-Based Care Attributed Lives stood at 1.38 million, above the two-analyst average estimate of 1.3 million [4] Stock Performance - Over the past month, Privia Health's shares have returned -6.7%, contrasting with the Zacks S&P 500 composite's increase of +1.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
